LK

Likhith Kumar Radhakrishna Talagavara

Active Director Designated Partner DIN 11587232
DIN 11587232 First appointment Mar 2026
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since Mar 2026
Shareholding value β€’β€’β€’β€’ Premium profile

About Likhith Kumar Radhakrishna Talagavara

Data last updated:

Likhith Kumar Radhakrishna Talagavara is a Designated Partner at Uromed Healthcare Plus Llp (since 2026).

DIN 11587232
Primary Designation Designated Partner
First Appointment 06 Mar 2026

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner06 Mar 20262026Active

Board colleagues of Likhith Kumar Radhakrishna Talagavara

NameDINCompanyDesignation
Kushal Kumar Talagavara Radhakrishna11587233Uromed Healthcare Plus LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Uromed Healthcare Plus Llp
Premium access

Shareholding and investment profile for Likhith Kumar Radhakrishna Talagavara

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Likhith Kumar Radhakrishna Talagavara

Likhith Kumar Radhakrishna Talagavara currently holds 1 directorship: Uromed Healthcare Plus Llp (Designated Partner, since 06 Mar 2026).

Likhith Kumar Radhakrishna Talagavara was first appointed on 06 Mar 2026 as Designated Partner at Uromed Healthcare Plus Llp.

The current boards of Likhith Kumar Radhakrishna Talagavara's companies include Kushal Kumar Talagavara Radhakrishna (Uromed Healthcare Plus Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available